Osaka International Cancer Institute

Parexel, Osaka International Cancer Institute partner in Japan

Monday, August 21, 2017

Parexel International, a global biopharmaceutical services provider, and Osaka International Cancer Institute have formed an alliance to advance clinical development in Japan. The partnership will aim to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and hematology, accelerating the development of innovative and effective new cancer treatments for patients.

[Read More]